Avanos Medical (NYSE: AVNS) SVP has shares withheld to cover RSU taxes

Rhea-AI Filing Summary

Avanos Medical senior vice president of operations Sigfrido Delgado had shares withheld to cover taxes on a stock award. On the vesting of 16,300 time-based restricted share units, 4,264 shares of common stock were surrendered to Avanos Medical to satisfy tax withholding obligations. Each restricted share unit is economically equivalent to one common share. Following this non-market tax-withholding disposition, Delgado directly holds 55,741 shares of Avanos Medical common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Delgado Sigfrido

Role SVP, Operations

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	4,264	$24.64	$105K

Holdings After Transaction: Common Stock — 55,741 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Tax-withholding shares: 4,264 shares Withholding price: $24.64 per share TRSUs vested: 16,300 units +2 more

5 metrics

Tax-withholding shares 4,264 shares Common stock surrendered for tax withholding on award vesting

Withholding price $24.64 per share Value used for the 4,264 surrendered shares

TRSUs vested 16,300 units Time-based restricted share units vesting into common stock

Shares held after 55,741 shares Direct Avanos Medical common stock ownership after transaction

Transaction date April 22, 2026 Effective date of tax-withholding share disposition

Key Terms

time-based restricted share units (TRSUs), tax withholding obligations, economic equivalent of one share of Common Stock

3 terms

time-based restricted share units (TRSUs) financial

"Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 16,300 time-based restricted share units (TRSUs)"

tax withholding obligations financial

"Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting"

economic equivalent of one share of Common Stock financial

"Each TRSU is the economic equivalent of one share of Common Stock"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Delgado Sigfrido

(Last) (First) (Middle)

5405 WINDWARD PKWY

(Street)

ALPHARETTA GEORGIA 30004-4667

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
AVANOS MEDICAL, INC. [ AVNS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Operations

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/22/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/22/2026		F(1)		4,264	D	$24.64	55,741	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 16,300 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on April 22, 2025 and (ii) vested on April 22, 2026. Each TRSU is the economic equivalent of one share of Common Stock.

Remarks:

	/s/ John Hurley, as attorney-in-fact for Sigfrido Delgado	04/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What transaction did Avanos Medical (AVNS) SVP Sigfrido Delgado report?

Sigfrido Delgado reported a tax-related share disposition, not an open-market trade. 4,264 Avanos Medical common shares were surrendered back to the company to cover tax withholding triggered by the vesting of 16,300 time-based restricted share units.

How many Avanos Medical (AVNS) shares were withheld for taxes in this Form 4?

The filing shows 4,264 Avanos Medical common shares were surrendered. This occurred when a larger stock award vested, and the company took a portion of the new shares to satisfy Delgado’s tax withholding obligations instead of a cash payment.

What stock award vested for Avanos Medical (AVNS) SVP Delgado?

A grant of 16,300 time-based restricted share units vested for Delgado. Each unit is economically equivalent to one share of Avanos Medical common stock, so the vesting effectively delivered 16,300 shares before a portion was withheld to pay taxes.

How many Avanos Medical (AVNS) shares does Delgado hold after this transaction?

After the tax-withholding disposition, Delgado directly holds 55,741 Avanos Medical common shares. This figure reflects his remaining position following surrender of 4,264 shares to the company for tax withholding linked to the vesting restricted share units.

Was this Avanos Medical (AVNS) insider transaction an open-market sale?

No, the Form 4 describes a tax-withholding disposition, not a market sale. Shares were surrendered back to Avanos Medical to cover tax obligations when restricted share units vested, rather than sold on a stock exchange to outside buyers.

What are time-based restricted share units (TRSUs) in the Avanos (AVNS) filing?

Time-based restricted share units are stock awards that convert into shares after a service period. In this case, 16,300 TRSUs vested for Delgado, each economically equal to one Avanos Medical common share, triggering associated tax withholding in shares.